St Jude Medical receives CE Mark for Ellipse and SJM Assura devices

St Jude Medical has announced that its next-generation Ellipse and SJM Assura high-voltage devices have been granted European CE Mark approval.

This new portfolio of implantable cardioverter defibrillators and cardiac resynchronisation therapy defibrillators has been designed to lower the risk for lead abrasion and offer various safety features to enhance care quality.

The DynamicTx Over-Current Detection Algorithm technology automatically adjusts shocking configurations to ensure the delivery of high-voltage therapy even if an electrical short occurs in one part of the system.

Other beneficial features of the new devices include their low-friction coating and SecureSense RV Lead Noise Discrimination.

Dr Eric Fain, president of the St Jude Medical implantable electronic systems division, said: "The goal for this innovative portfolio of devices is to bring implantable defibrillation reliability and patient safety to the next level."

Last month, the firm received a CE Mark for the Allure Quadra cardiac resynchronisation therapy pacemaker, the first quadripolar device of its kind.